Valentina André
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Valentina André has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Anna Cariboni
Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy
12 shared publications - Sasha Rose Howard
Centre for Endocrinology, William Harvey Research Institute Queen Mary University of London London UK
6 shared publications - Leo Dunkel
Queen Mary University of London
5 shared publications - Giovanna D'AMico
Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
4 shared publications - Roberto Oleari
University of Milan, Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”, Via Balzaretti 9, 20133 Milan, Italy
4 shared publications - Antonella Lettieri
University of Milan, Department of Pharmacological and Biomolecular Sciences “Rodolfo Paoletti”, Via Balzaretti 9, 20133 Milan, Italy
3 shared publications
Latest Publications
- Open Access
- 7 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability
Innervation of the hypothalamic median eminence by Gonadotropin-Releasing Hormone (GnRH) neurons is vital to ensure puberty onset and successful reproduction. However, the molecular and cellular mechanisms underlying median eminence development and pubertal timing are incompletely understood. Here we show that Semaphorin-6A is strongly expressed by median eminence-resident oligodendrocytes positioned adjacent to GnRH neuron projections and fenestrated capillaries, and that Semaphorin-6A is required for GnRH neuron innervation and puberty onset. In vitro and in vivo experiments reveal an unexpected function for Semaphorin-6A, via its receptor Plexin-A2, in the control of median eminence vascular permeability to maintain neuroendocrine homeostasis. To support the significance of these findings in humans, we identify patients with delayed puberty carrying a novel pathogenic variant of SEMA6A. In all, our data reveal a role for Semaphorin-6A in regulating GnRH neuron patterning by tuning the median eminence vascular barrier and thereby controlling puberty onset.
- 7 December 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-20
Open AccessSEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability
Innervation of the hypothalamic median eminence by Gonadotropin-Releasing Hormone (GnRH) neurons is vital to ensure puberty onset and successful reproduction. However, the molecular and cellular mechanisms underlying median eminence development and pubertal timing are incompletely understood. Here we show that Semaphorin-6A is strongly expressed by median eminence-resident oligodendrocytes positioned adjacent to GnRH neuron projections and fenestrated capillaries, and that Semaphorin-6A is required for GnRH neuron innervation and puberty onset. In vitro and in vivo experiments reveal an unexpected function for Semaphorin-6A, via its receptor Plexin-A2, in the control of median eminence vascular permeability to maintain neuroendocrine homeostasis. To support the significance of these findings in humans, we identify patients with delayed puberty carrying a novel pathogenic variant of SEMA6A. In all, our data reveal a role for Semaphorin-6A in regulating GnRH neuron patterning by tuning the median eminence vascular barrier and thereby controlling puberty onset.
- Open Access
Combined omic analyses reveal novel loss-of-function NLGN3 variants in GnRH deficiency and autism
Gonadotropin releasing hormone (GnRH) deficiency is a disorder characterized by absent or delayed puberty, with largely unknown genetic causes. The purpose of this study was to obtain and exploit gene expression profiles of GnRH neurons during development to unveil novel biological mechanisms and genetic determinants underlying GnRH deficiency (GD). Here, we combined bioinformatic analyses of primary embryonic and immortalized GnRH neuron transcriptomes with exome sequencing from GD patients to identify candidate causative genes. Among differentially expressed and filtered transcripts, we found loss-of-function (LoF) variants of the autism-linked Neuroligin 3 ( NLGN3 ) gene in two unrelated patients co- presenting with GD and neurodevelopmental traits. We demonstrated that NLGN3 is upregulated in maturing GnRH neurons and that NLGN3 wild type, but not mutant proteins, promotes neuritogenesis when overexpressed in developing GnRH cells. Our data represent proof-of-principle that this complementary approach can identify novel candidate GD genes and demonstrate that LoF NLGN3 variants may contribute to GD. This novel genotype- phenotype correlation implies common genetic mechanisms underlying neurodevelopmental disorders, such as GD and autistic spectrum disorder.
Open AccessCombined omic analyses reveal novel loss-of-function NLGN3 variants in GnRH deficiency and autism
Gonadotropin releasing hormone (GnRH) deficiency is a disorder characterized by absent or delayed puberty, with largely unknown genetic causes. The purpose of this study was to obtain and exploit gene expression profiles of GnRH neurons during development to unveil novel biological mechanisms and genetic determinants underlying GnRH deficiency (GD). Here, we combined bioinformatic analyses of primary embryonic and immortalized GnRH neuron transcriptomes with exome sequencing from GD patients to identify candidate causative genes. Among differentially expressed and filtered transcripts, we found loss-of-function (LoF) variants of the autism-linked Neuroligin 3 ( NLGN3 ) gene in two unrelated patients co- presenting with GD and neurodevelopmental traits. We demonstrated that NLGN3 is upregulated in maturing GnRH neurons and that NLGN3 wild type, but not mutant proteins, promotes neuritogenesis when overexpressed in developing GnRH cells. Our data represent proof-of-principle that this complementary approach can identify novel candidate GD genes and demonstrate that LoF NLGN3 variants may contribute to GD. This novel genotype- phenotype correlation implies common genetic mechanisms underlying neurodevelopmental disorders, such as GD and autistic spectrum disorder.
- 30 October 2017
- Published by Bioscientifica in Endocrine Abstracts
Patients with self-limited delayed puberty harbour mutations in multiple genes controlling GnRH neuronal development
Objectives: Abnormal pubertal timing affects >4% of adolescents and is associated with adverse health outcomes. Up to 80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority the neuroendocrine pathophysiology and genetic regulation remain unclear. Mis-regulation of the embryonic migration of GnRH neurons has been implicated in the pathogenesis of DP (Howard et al 2016). We hypothesised that new candidates for the genetic basis of DP could be identified using expression data on genes up- or down-regulated during GnRH neuronal migration. Methods: We performed whole exome sequencing (WES) in 160 members of 67 families from our self-limited DP patient cohort, and filtered the data for genes with rare, predicted deleterious variants that segregated with trait within families. These data were firstly examined for overlap with gene expression data from microarray analysis of GnRH:GFP primary rat neurons at E14, E17 and E20. Secondly the data were compared to a microarray analysis of genes differentially expressed in GN11 (immature and migratory) and GT1-7 (mature and non-migratory) immortalised GnRH neurons. Results: After WES, 7350 genes contained rare, predicted deleterious variants that passed quality control. Microarray analysis identified 677 genes with significant (fold change > 2) up- or down-regulation during the time period of embryonic GnRH neuronal migration, and 102 differently expressed between GN11 and GT1-7 cells. 265 genes identified as significantly up- or down-regulated between GnRH:GFP primary rat neurons at E14 and at E20, and 33 genes reaching statistical significance for differential expression between GN11 and GT1-7 cells, were also identified as potentially pathogenic in self-limited DP patients. These include the G-protein coupled receptor LGR4, the neuronal growth regulator NEGR1 and several other neuronal chemokines or axonal growth guidance molecules. Conclusions: This analysis has yielded several interesting new rare, potentially pathogenic variants in genes implicated in GnRH neuronal migration and development in 12 families from our cohort. Whilst these candidates need to be functionally validated, these data provides further evidence for the importance of GnRH neuronal migration in the timing of puberty onset.
- 30 October 2017
- Published by Bioscientifica in Endocrine Abstracts
Patients with self-limited delayed puberty harbour mutations in multiple genes controlling GnRH neuronal development
Objectives: Abnormal pubertal timing affects >4% of adolescents and is associated with adverse health outcomes. Up to 80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority the neuroendocrine pathophysiology and genetic regulation remain unclear. Mis-regulation of the embryonic migration of GnRH neurons has been implicated in the pathogenesis of DP (Howard et al 2016). We hypothesised that new candidates for the genetic basis of DP could be identified using expression data on genes up- or down-regulated during GnRH neuronal migration. Methods: We performed whole exome sequencing (WES) in 160 members of 67 families from our self-limited DP patient cohort, and filtered the data for genes with rare, predicted deleterious variants that segregated with trait within families. These data were firstly examined for overlap with gene expression data from microarray analysis of GnRH:GFP primary rat neurons at E14, E17 and E20. Secondly the data were compared to a microarray analysis of genes differentially expressed in GN11 (immature and migratory) and GT1-7 (mature and non-migratory) immortalised GnRH neurons. Results: After WES, 7350 genes contained rare, predicted deleterious variants that passed quality control. Microarray analysis identified 677 genes with significant (fold change > 2) up- or down-regulation during the time period of embryonic GnRH neuronal migration, and 102 differently expressed between GN11 and GT1-7 cells. 265 genes identified as significantly up- or down-regulated between GnRH:GFP primary rat neurons at E14 and at E20, and 33 genes reaching statistical significance for differential expression between GN11 and GT1-7 cells, were also identified as potentially pathogenic in self-limited DP patients. These include the G-protein coupled receptor LGR4, the neuronal growth regulator NEGR1 and several other neuronal chemokines or axonal growth guidance molecules. Conclusions: This analysis has yielded several interesting new rare, potentially pathogenic variants in genes implicated in GnRH neuronal migration and development in 12 families from our cohort. Whilst these candidates need to be functionally validated, these data provides further evidence for the importance of GnRH neuronal migration in the timing of puberty onset.
- Open Access
- 27 April 2017
- Published by MDPI AG in Brain Sciences
- Vol. 7 (5) , 48
In Vitro, Ex Vivo and In Vivo Techniques to Study Neuronal Migration in the Developing Cerebral Cortex
Neuronal migration is a fundamental biological process that underlies proper brain development and neuronal circuit formation. In the developing cerebral cortex, distinct neuronal populations, producing excitatory, inhibitory and modulatory neurotransmitters, are generated in different germinative areas and migrate along various routes to reach their final positions within the cortex. Different technical approaches and experimental models have been adopted to study the mechanisms regulating neuronal migration in the cortex. In this review, we will discuss the most common in vitro, ex vivo and in vivo techniques to visualize and study cortical neuronal migration.
- 27 April 2017
- Published by MDPI AG in Brain Sciences
- Vol. 7 (5) , 48
Open AccessIn Vitro, Ex Vivo and In Vivo Techniques to Study Neuronal Migration in the Developing Cerebral Cortex
Neuronal migration is a fundamental biological process that underlies proper brain development and neuronal circuit formation. In the developing cerebral cortex, distinct neuronal populations, producing excitatory, inhibitory and modulatory neurotransmitters, are generated in different germinative areas and migrate along various routes to reach their final positions within the cortex. Different technical approaches and experimental models have been adopted to study the mechanisms regulating neuronal migration in the cortex. In this review, we will discuss the most common in vitro, ex vivo and in vivo techniques to visualize and study cortical neuronal migration.
- Open Access
- 13 April 2016
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 8 (6) , 626-642
IGSF10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 13 April 2016
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 8 (6) , 626-642
Open AccessIGSF10 mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 4 March 2016
- Vol. 41 (2) , 266-78
The role of semaphorin signaling in the etiology of hypogonadotropic hypogonadism.
In mammals fertility depends on timely onset and cyclic secretion of gonadotropin-releasing hormone (GnRH), secreted by scattered hypothalamic neurons (GnRH neurons). These cells originate in the nasal placode and migrate first in the nasal compartment, then through the cribriform plate and finally across the basal forebrain, before they set in their final position in the hypothalamus. This long journey is regulated by many different factors that could be mutated in neuroendocrine syndromes such as congenital hypogonadotropic hypogonadism (CHH), Kallmann Syndrome (KS) and CHARGE syndrome. Recently, semaphorins, a large family of molecules, previously discovered as axon guidance cues, are emerging as key regulators of the neuroendocrine control of GnRH neurons and are acquiring an increasing role in the etiopathogenesis of CHH and KS. Specifically, semaphorins play a multifaceted action in GnRH neuron biology: on one hand regulating their migration and survival during embryonic development and, on the other, controlling the plasticity of the median eminence (ME) in terms of its response to varying sex steroid hormone levels. In this review we will focus our attention on recent studies describing the roles of different semaphorins in the normal and pathological biology of the GnRH neuronal system.
- 4 March 2016
- Vol. 41 (2) , 266-78
The role of semaphorin signaling in the etiology of hypogonadotropic hypogonadism.
In mammals fertility depends on timely onset and cyclic secretion of gonadotropin-releasing hormone (GnRH), secreted by scattered hypothalamic neurons (GnRH neurons). These cells originate in the nasal placode and migrate first in the nasal compartment, then through the cribriform plate and finally across the basal forebrain, before they set in their final position in the hypothalamus. This long journey is regulated by many different factors that could be mutated in neuroendocrine syndromes such as congenital hypogonadotropic hypogonadism (CHH), Kallmann Syndrome (KS) and CHARGE syndrome. Recently, semaphorins, a large family of molecules, previously discovered as axon guidance cues, are emerging as key regulators of the neuroendocrine control of GnRH neurons and are acquiring an increasing role in the etiopathogenesis of CHH and KS. Specifically, semaphorins play a multifaceted action in GnRH neuron biology: on one hand regulating their migration and survival during embryonic development and, on the other, controlling the plasticity of the median eminence (ME) in terms of its response to varying sex steroid hormone levels. In this review we will focus our attention on recent studies describing the roles of different semaphorins in the normal and pathological biology of the GnRH neuronal system.
- 2 March 2016
- Vol. 41 (2) , 250-65
The zebrafish: an emerging animal model for investigating the hypothalamic regulation of reproduction.
Gonadotropin-releasing hormone (GnRH) neurons have a pivotal role in the physiological functions of hypotahlamic-pituitary-gonadal (HPG) axis. The pulsatile releasing of GnRH hormone into the hypophyseal portal circulation at the median eminence represent the first domino in the HPG cascade of events that regulate the development, fertility and aging in all vertebrates. These neurons principally originate in the olfactory placode and migrate during early embryonal stages into the hypothalamus. Alterations in developmental processes or in the releasing of GnRH hormone lead to a rare and complex disorder of the reproductive axis called congenital hypogonadotropic hypogonadism (CHH). Genetic screening of human patients and the use of model systems have led to the identification of several genes involved in the CHH pathogenesis underlying its oligogenic nature. Nevertheless CHH remains, for a large cohort of patients, idiopathic and GnRH neurogenesis processes not fully understood. This is due to intrinsic difficulties that exist in the analysis of earliest embryonic developmental stages and in the methodologies developed to study the CHH-causing genes. In this regard, zebrafish embryos, on account of its external fertilization and development, allow a real-time analysis that could overcome some of the above mentioned limitations. Moreover, the recent availability of several transgenic zebrafish reporter lines makes it an excellent model for the study of the oligogenic mechanisms leading to CHH.
- 2 March 2016
- Vol. 41 (2) , 250-65
The zebrafish: an emerging animal model for investigating the hypothalamic regulation of reproduction.
Gonadotropin-releasing hormone (GnRH) neurons have a pivotal role in the physiological functions of hypotahlamic-pituitary-gonadal (HPG) axis. The pulsatile releasing of GnRH hormone into the hypophyseal portal circulation at the median eminence represent the first domino in the HPG cascade of events that regulate the development, fertility and aging in all vertebrates. These neurons principally originate in the olfactory placode and migrate during early embryonal stages into the hypothalamus. Alterations in developmental processes or in the releasing of GnRH hormone lead to a rare and complex disorder of the reproductive axis called congenital hypogonadotropic hypogonadism (CHH). Genetic screening of human patients and the use of model systems have led to the identification of several genes involved in the CHH pathogenesis underlying its oligogenic nature. Nevertheless CHH remains, for a large cohort of patients, idiopathic and GnRH neurogenesis processes not fully understood. This is due to intrinsic difficulties that exist in the analysis of earliest embryonic developmental stages and in the methodologies developed to study the CHH-causing genes. In this regard, zebrafish embryos, on account of its external fertilization and development, allow a real-time analysis that could overcome some of the above mentioned limitations. Moreover, the recent availability of several transgenic zebrafish reporter lines makes it an excellent model for the study of the oligogenic mechanisms leading to CHH.
- Top Cited Papers
- 29 December 2015
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 22 (3) , 358-381
GnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Human reproduction depends on an intact hypothalamic–pituitary–gonadal (HPG) axis. Hypothalamic gonadotrophin-releasing hormone (GnRH) has been recognized, since its identification in 1971, as the central regulator of the production and release of the pituitary gonadotrophins that, in turn, regulate the gonadal functions and the production of sex steroids. The characteristic peculiar development, distribution and episodic activity of GnRH-producing neurons have solicited an interdisciplinary interest on the etiopathogenesis of several reproductive diseases. The more recent identification of a GnRH/GnRH receptor (GnRHR) system in both the human endometrium and ovary has widened the spectrum of action of the peptide and of its analogues beyond its hypothalamic function. An analysis of research and review articles published in international journals until June 2015 has been carried out to comprehensively summarize both the well established and the most recent knowledge on the physiopathology of the GnRH system in the central and peripheral control of female reproductive functions and diseases. This review focuses on the role of GnRH neurons in the control of the reproductive axis. New knowledge is accumulating on the genetic programme that drives GnRH neuron development to ameliorate the diagnosis and treatment of GnRH deficiency and consequent delayed or absent puberty. Moreover, a better understanding of the mechanisms controlling the episodic release of GnRH during the onset of puberty and the ovulatory cycle has enabled the pharmacological use of GnRH itself or its synthetic analogues (agonists and antagonists) to either stimulate or to block the gonadotrophin secretion and modulate the functions of the reproductive axis in several reproductive diseases and in assisted reproduction technology. Several inputs from other neuronal populations, as well as metabolic, somatic and age-related signals, may greatly affect the functions of the GnRH pulse generator during the female lifespan; their modulation may offer new possible strategies for diagnostic and therapeutic interventions. A GnRH/GnRHR system is also expressed in female reproductive tissues (e.g. endometrium and ovary), both in normal and pathological conditions. The expression of this system in the human endometrium and ovary supports its physiological regulatory role in the processes of trophoblast invasion of the maternal endometrium and embryo implantation as well as of follicular development and corpus luteum functions. The GnRH/GnRHR system that is expressed in diseased tissues of the female reproductive tract (both benign and malignant) is at present considered an effective molecular target for the development of novel therapeutic approaches for these pathologies. GnRH agonists are also considered as a promising therapeutic approach to counteract ovarian failure in young female patients undergoing chemotherapy. Increasing knowledge about the regulation of GnRH pulsatile release, as well as the therapeutic use of its analogues, offers interesting new perspectives in the diagnosis, treatment and outcome of female reproductive disorders, including tumoral and iatrogenic diseases.
- 29 December 2015
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 22 (3) , 358-381
Top Cited PapersGnRH and GnRH receptors in the pathophysiology of the human female reproductive system
Human reproduction depends on an intact hypothalamic–pituitary–gonadal (HPG) axis. Hypothalamic gonadotrophin-releasing hormone (GnRH) has been recognized, since its identification in 1971, as the central regulator of the production and release of the pituitary gonadotrophins that, in turn, regulate the gonadal functions and the production of sex steroids. The characteristic peculiar development, distribution and episodic activity of GnRH-producing neurons have solicited an interdisciplinary interest on the etiopathogenesis of several reproductive diseases. The more recent identification of a GnRH/GnRH receptor (GnRHR) system in both the human endometrium and ovary has widened the spectrum of action of the peptide and of its analogues beyond its hypothalamic function. An analysis of research and review articles published in international journals until June 2015 has been carried out to comprehensively summarize both the well established and the most recent knowledge on the physiopathology of the GnRH system in the central and peripheral control of female reproductive functions and diseases. This review focuses on the role of GnRH neurons in the control of the reproductive axis. New knowledge is accumulating on the genetic programme that drives GnRH neuron development to ameliorate the diagnosis and treatment of GnRH deficiency and consequent delayed or absent puberty. Moreover, a better understanding of the mechanisms controlling the episodic release of GnRH during the onset of puberty and the ovulatory cycle has enabled the pharmacological use of GnRH itself or its synthetic analogues (agonists and antagonists) to either stimulate or to block the gonadotrophin secretion and modulate the functions of the reproductive axis in several reproductive diseases and in assisted reproduction technology. Several inputs from other neuronal populations, as well as metabolic, somatic and age-related signals, may greatly affect the functions of the GnRH pulse generator during the female lifespan; their modulation may offer new possible strategies for diagnostic and therapeutic interventions. A GnRH/GnRHR system is also expressed in female reproductive tissues (e.g. endometrium and ovary), both in normal and pathological conditions. The expression of this system in the human endometrium and ovary supports its physiological regulatory role in the processes of trophoblast invasion of the maternal endometrium and embryo implantation as well as of follicular development and corpus luteum functions. The GnRH/GnRHR system that is expressed in diseased tissues of the female reproductive tract (both benign and malignant) is at present considered an effective molecular target for the development of novel therapeutic approaches for these pathologies. GnRH agonists are also considered as a promising therapeutic approach to counteract ovarian failure in young female patients undergoing chemotherapy. Increasing knowledge about the regulation of GnRH pulsatile release, as well as the therapeutic use of its analogues, offers interesting new perspectives in the diagnosis, treatment and outcome of female reproductive disorders, including tumoral and iatrogenic diseases.
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty
Background: Abnormal pubertal timing affects over 4% of adolescents and is associated with adverse health and psychosocial outcomes. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. However, despite this strong heritability, little is known about the genetic control of human puberty. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. Methods: We performed whole exome sequencing in 52 members of seven families from our patient cohort with DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. The functional consequences of the identified mutations in one candidate gene were interrogated via expression of WT and mutant proteins in mammalian cells. For this gene we defined tissue expression in human and mouse embryos by in situ hybridization and immunohistochemistry. The effects of gene knockdown were investigated via in vitro neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently labeled GnRH neurons. Results: We identified four rare mutations in IGSF10 in ten unrelated families, which are tightly associated with the DP trait within our cohort (P=3.47×10−4). The identified mutations are in evolutionarily conserved positions, and two mutations result in intracellular retention with failure in secretion of the N-terminal fragment of the protein. IGSF10 mRNA is strongly expressed in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the zebrafish model. Conclusions: We present our novel finding that mutations in IGSF10 cause delayed puberty in humans, through misregulation of GnRH neuronal migration during embryonic development.
- 4 November 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty
Background: Abnormal pubertal timing affects over 4% of adolescents and is associated with adverse health and psychosocial outcomes. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. However, despite this strong heritability, little is known about the genetic control of human puberty. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but in the majority of patients the neuroendocrine pathophysiology and its genetic regulation remain unclear. Methods: We performed whole exome sequencing in 52 members of seven families from our patient cohort with DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. The functional consequences of the identified mutations in one candidate gene were interrogated via expression of WT and mutant proteins in mammalian cells. For this gene we defined tissue expression in human and mouse embryos by in situ hybridization and immunohistochemistry. The effects of gene knockdown were investigated via in vitro neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently labeled GnRH neurons. Results: We identified four rare mutations in IGSF10 in ten unrelated families, which are tightly associated with the DP trait within our cohort (P=3.47×10−4). The identified mutations are in evolutionarily conserved positions, and two mutations result in intracellular retention with failure in secretion of the N-terminal fragment of the protein. IGSF10 mRNA is strongly expressed in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the zebrafish model. Conclusions: We present our novel finding that mutations in IGSF10 cause delayed puberty in humans, through misregulation of GnRH neuronal migration during embryonic development.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
Background: Timing of puberty is associated with height, cardiovascular health and cancer risk, with a significant public health impact. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but the underlying genetic background is unknown. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with self-limited DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. For one candidate gene we defined tissue expression in human and mouse embryos. The effects of gene knockdown were investigated via neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently-labelled GnRH neurons. N-terminal fragment mutations were interrogated via expression in mammalian cells. Results: We identified four rare heterozygous variants in IGSF10 in 29 members of ten unrelated families. All four variants were in evolutionarily conserved positions and were predicted by in silico analysis to have a deleterious effect on protein function. Statistical tests showed a significant difference in the prevalence of these mutations within DP cases compared to a general population (P=4.46×10−3), and a significant association between these mutations and the delayed puberty trait within our cohort (P=3.47×10−4). IGSF10 mRNA shows strong expression in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the transgenic zebrafish model. Reduced secretion of mutant protein was demonstrated by western blotting. Conclusions: We present our novel finding that IGSF10 mutations contribute to the phenotype of self-limited delayed puberty in humans, through impairment of migration of GnRH neurons during embryonic development.
- 12 October 2015
- Published by Bioscientifica in Endocrine Abstracts
Mutations in IGSF10 cause self-limited delayed puberty, via disturbance of GnRH neuronal migration
Background: Timing of puberty is associated with height, cardiovascular health and cancer risk, with a significant public health impact. Previous studies estimate that 60–80% of variation in the timing of pubertal onset is genetically determined. Self-limited delayed puberty (DP) segregates in an autosomal dominant pattern, but the underlying genetic background is unknown. Methods: We performed whole exome sequencing in 111 members of 18 families from our patient cohort with self-limited DP, with follow-up targeted re-sequencing of candidate genes in a further 42 families. For one candidate gene we defined tissue expression in human and mouse embryos. The effects of gene knockdown were investigated via neuronal migration assays, and in vivo using a transgenic zebrafish model with fluorescently-labelled GnRH neurons. N-terminal fragment mutations were interrogated via expression in mammalian cells. Results: We identified four rare heterozygous variants in IGSF10 in 29 members of ten unrelated families. All four variants were in evolutionarily conserved positions and were predicted by in silico analysis to have a deleterious effect on protein function. Statistical tests showed a significant difference in the prevalence of these mutations within DP cases compared to a general population (P=4.46×10−3), and a significant association between these mutations and the delayed puberty trait within our cohort (P=3.47×10−4). IGSF10 mRNA shows strong expression in the nasal mesenchyme in mouse and human embryos, during the time-period when GnRH neurons migrate from their nasal origin towards the hypothalamus. IGSF10 knockdown caused reduced migration of immature GnRH neurons in the in vitro analysis, and perturbed migration and extension of GnRH neurons in the transgenic zebrafish model. Reduced secretion of mutant protein was demonstrated by western blotting. Conclusions: We present our novel finding that IGSF10 mutations contribute to the phenotype of self-limited delayed puberty in humans, through impairment of migration of GnRH neurons during embryonic development.